Sustainable Insight Capital Management, LLC Gilead Sciences, Inc. Transaction History

Sustainable Insight Capital Management, LLC

$220 Million
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $217,200 - $244,632	3,763 New	3,763 $228,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $307,207 - $384,964	-5,304 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $81,164 - $92,123	-1,251 Reduced 19.08%	5,304 $385,000
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $142,487 - $153,728	2,105 Added 47.3%	6,555 $458,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $4,696 - $5,131	74 Added 1.69%	4,450 $306,000
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $48,000 - $54,767	-800 Reduced 15.46%	4,376 $283,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $80,443 - $91,661	1,420 Added 37.81%	5,176 $302,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $6,251 - $6,900	-100 Reduced 2.59%	3,756 $238,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $238,570 - $267,529	3,856 New	3,856 $261,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $172,539 - $225,150	-2,850 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $203,148 - $224,922	2,850 New	2,850 $220,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sustainable Insight Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sustainable Insight Capital Management, LLC with notifications on news.

Account